For the Inventor, By the Inventor

Enter assignee name

Austin, TX, United States of America

Ambion, Inc.

USPTO Granted Patents = 25

% Expired Patents = 16.0

EPO Patents = 6

Trademarks = 16

Forward Citations = 921

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Matthew M Winkler (15 out of 21 patents)

Marianna M Goldrick (8 out of 14 patents)

Brittan L Pasloske (7 out of 21 patents)

4. Dwight B DuBois (4 out of 11 patents)

5. Susan C Milburn (3 out of 3 patents)

6. Eric S Lader (3 out of 3 patents)

7. David Allen Brown (2 out of 74 patents)

8. William Wu (2 out of 8 patents)

9. W Antoni Kudlicki (2 out of 4 patents)

10. Gary J Latham (1 out of 17 patents)

11. Richard Conrad (1 out of 23 patents)

12. George L Murphy (1 out of 6 patents)

13. Mike Byrom (1 out of 19 patents)

14. Dmitriy Ovcharenko (1 out of 17 patents)

15. Jon Kemppainen (1 out of 5 patents)

25 patents: Sort by Forward Citations

1. 7250270 - Methods and compositions for preparing tissue samples for RNA extraction (2007-07-31),

2. 7163793 - Nuclease inhibitor cocktail (2007-01-16),

3. 7067298 - Compositions and methods of using a synthetic Dnase I (2006-06-27),

4. 7033749 - Ribonuclease resistant RNA preparation and utilization (2006-04-25),

5. 6994963 - Methods for recombinatorial nucleic acid synthesis (2006-02-07),

6. 6897069 - System and method for electroporating a sample (2005-05-24),

7. 6891032 - Methods and compositions for stripping nucleic acids (2005-05-10),

8. 6825340 - Methods and reagents for inactivating ribonucleases (2004-11-30),

9. 6812341 - High efficiency mRNA isolation methods and compositions (2004-11-02),

10. 6777210 - Method and reagents for inactivating ribonucleases RNase A, RNase I and RNase T1 (2004-08-17),

11. 6664379 - Nuclease inhibitor cocktail (2003-12-16),

12. 6586219 - Compositions and methods for increasing the yields of the in vitro RNA transcription and other polynucleotide synthetic reactions (2003-07-01),

13. 6586218 - Compositions and methods for increasing the yields of in vitro RNA transcription and other polynucleotide synthetic reactions (2003-07-01),

14. 6528641 - Methods and reagents for preserving RNA in cell and tissue samples (2003-03-04),

15. 6365731 - Stripping nucleic acids with iodine and sodium thiosulfate (2002-04-02),

Ambion, Inc. is a leading biotechnology company specializing in molecular biology research and RNA analysis. With over 20 years of experience, the company offers a wide range of innovative products and services for scientists and researchers worldwide. Ambion's cutting-edge technologies and solutions empower researchers to advance their studies in genomics, gene expression, and RNA interference. By providing high-quality reagents, kits, and instruments, Ambion is committed to enabling breakthrough discoveries and driving advancements in life sciences.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

25 Patents

#124 in Austin, TX

#777 in Texas

#13,320 in US

#25,614 in the World

Austin, TX, United States of America

Ambion, Inc.

Forward Citations = 921

25 inventors:

Matthew M Winkler (15 out of 21 patents)

Marianna M Goldrick (8 out of 14 patents)

Brittan L Pasloske (7 out of 21 patents)

4. Dwight B DuBois (4 out of 11 patents)

5. Susan C Milburn (3 out of 3 patents)

Please report any incorrect information to [email protected]

Loading…